Confusion Persists Around the Interchangeability Designation for Biosimilars
The legal and common uses of “interchangeability” continue to be conflated.
United States United Kingdom Aliaksandr Marko European Medicines Agency Head Of Medicine Biosimilar Medicinal Products Working Party European Union
Source: pharmacytimes.com